Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Nelson

Showing results (201-210 of 273) with videos related to

Pageof 28
Sort By:
Human Genetics|March 1, 1992
Mucopolysaccharidosis type I (Hurler syndrome): linkage disequilibrium indicates the presence of a major alleleH S Scott, P V Nelson, A Cooper, et al.
The Journal of Nursing Administration|February 18, 2015
Pioneering through chaosNora E Warshawsky, M Lindell Joseph, Debra L Fowler, et al.
Genomics|December 1, 1992
An 86-bp VNTR within IDUA is the basis of the D4S111 polymorphic locusH S Scott, P V Nelson, M E MacDonald, et al.
Human Mutation|January 1, 1994
Mutation analysis of 19 North American mucopolysaccharidosis type I patients: identification of two additional frequent mutationsL A Clarke, P V Nelson, C L Warrington, et al.
Prenatal Diagnosis|September 1, 1994
Pitfalls in the prenatal diagnosis of peroxisomal beta-oxidation defects by chorionic villus samplingW F Carey, A Poulos, P Sharp, et al.
American Journal of Surgery|April 29, 2008
The effects of race and age on axillary lymph node involvement in breast cancer patients at a Midwestern safety-net hospitalRobert J Kenney, Jacob M Marszalek, Megan E McNally, et al.
Neurology|November 1, 1989
Controlled-release carbidopa/levodopa (Sinemet 50/200 CR4): clinical and pharmacokinetic studiesP A LeWitt, M V Nelson, R C Berchou, et al.
Clinical Neuropharmacology|April 1, 1989
Pharmacokinetic and pharmacodynamic modeling of L-dopa plasma concentrations and clinical effects in Parkinson's disease after SinemetM V Nelson, R C Berchou, P A Lewitt, et al.
Oncogene|January 20, 2022
Correction: Targeting the HIF-1α-IGFBP2 axis therapeutically reduces IGF1-AKT signaling and blocks the growth and metastasis of relapsed anaplastic Wilms tumorYan Liu, Marie V Nelson, Christopher Bailey, et al.
Journal of the American Veterinary Medical Association|August 17, 2010
Effect of colostral volume, interval between calving and first milking, and photoperiod on colostral IgG concentrations in dairy cowsDawn E Morin, Stephanie V Nelson, Eric D Reid, et al.
Pageof 28

Showing results (201-210 of 273) with videos related to

Sort By:
Pageof 28
Human Genetics|March 1, 1992
Mucopolysaccharidosis type I (Hurler syndrome): linkage disequilibrium indicates the presence of a major alleleH S Scott, P V Nelson, A Cooper, et al.
The Journal of Nursing Administration|February 18, 2015
Pioneering through chaosNora E Warshawsky, M Lindell Joseph, Debra L Fowler, et al.
Genomics|December 1, 1992
An 86-bp VNTR within IDUA is the basis of the D4S111 polymorphic locusH S Scott, P V Nelson, M E MacDonald, et al.
Human Mutation|January 1, 1994
Mutation analysis of 19 North American mucopolysaccharidosis type I patients: identification of two additional frequent mutationsL A Clarke, P V Nelson, C L Warrington, et al.
Prenatal Diagnosis|September 1, 1994
Pitfalls in the prenatal diagnosis of peroxisomal beta-oxidation defects by chorionic villus samplingW F Carey, A Poulos, P Sharp, et al.
American Journal of Surgery|April 29, 2008
The effects of race and age on axillary lymph node involvement in breast cancer patients at a Midwestern safety-net hospitalRobert J Kenney, Jacob M Marszalek, Megan E McNally, et al.
Neurology|November 1, 1989
Controlled-release carbidopa/levodopa (Sinemet 50/200 CR4): clinical and pharmacokinetic studiesP A LeWitt, M V Nelson, R C Berchou, et al.
Clinical Neuropharmacology|April 1, 1989
Pharmacokinetic and pharmacodynamic modeling of L-dopa plasma concentrations and clinical effects in Parkinson's disease after SinemetM V Nelson, R C Berchou, P A Lewitt, et al.
Oncogene|January 20, 2022
Correction: Targeting the HIF-1α-IGFBP2 axis therapeutically reduces IGF1-AKT signaling and blocks the growth and metastasis of relapsed anaplastic Wilms tumorYan Liu, Marie V Nelson, Christopher Bailey, et al.
Journal of the American Veterinary Medical Association|August 17, 2010
Effect of colostral volume, interval between calving and first milking, and photoperiod on colostral IgG concentrations in dairy cowsDawn E Morin, Stephanie V Nelson, Eric D Reid, et al.
Pageof 28